A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
|ClinicalTrials.gov Identifier: NCT01514760|
Recruitment Status : Completed
First Posted : January 23, 2012
Results First Posted : February 18, 2016
Last Update Posted : October 11, 2017
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Other: Mobile-based Asthma Action Plan||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||22 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2013|
Experimental: Mobile-based Asthma Action Plan
The mobile phone based application features will include ambulatory peak flow and asthma symptoms diary, individualized treatment plan for routine care and during episodes of acute asthma symptoms, and education components to reinforce asthma self-management concepts.
Other: Mobile-based Asthma Action Plan
The participant will be distributed a mobile phone (iPhone or Android) at the time of consent. The mobile-based Asthma Action Plan application will be provided on the mobile device. The mobile phone based application features will include ambulatory peak flow and asthma symptoms diary, individualized treatment plan for routine care and during episodes of acute asthma symptoms, and education components to reinforce asthma self-management concepts. Participants will receive 3 daily messages from the Asthma Action Plan mobile application. A fourth "rotating" message will be sent twice weekly.
- Mobile Asthma Action Plan (AAP) Usage [ Time Frame: Eight weeks ]Median number of days per week (range 0-7) the Asthma Action Plan was utilized to record routine (daily) symptoms or peak flow measurements.
- Number of Participants That Utilized the Asthma Action Plan [ Time Frame: Eight weeks ]The frequency of utilization of the Asthma Action Plan for acute symptoms among the study population will be measured and compared to responses of daily prompts that will ask participants to record whether they used rescue medication.
- Asthma Self-Efficacy for Adolescent Children [ Time Frame: Baseline and eight weeks ]The Child Self-Efficacy instrument is a 14 item validated questionnaire designed to measure the child's self-efficacy with regard to attack prevention and attack management. The child will be required to select one of 5 responses ranging from "not at all sure" (1 point); "a little bit sure" (2 points); "fairly sure" (3 points); "quite sure" (4 points) to "completely sure" (5 points). Total score range from 14-70. The higher score represent a greater degree of self-efficacy. The Cronbach's α reliability = 0.75. The child self-efficacy questionnaire will be administered at baseline (pre-intervention) and at the end of the intervention (post-intervention).
- Asthma Control Test™ Scores [ Time Frame: Baseline and eight weeks ]The Asthma Control Test™ (ACT) is a 5 question health survey used to measure asthma control in individuals 12 years of age and older. The total sum scores range from 5-25. Higher scores mean that asthma is more controlled. The ACT is an efficient, reliable, and valid method of measuring asthma control, with or without, lung functioning measures such as spirometry. ACT helps identify and detect asthma patients who are not well controlled. ACT scores were examined pre- and post-intervention. A score total of 19 or less means asthma may not be well controlled. The timeframe is during the past 4 weeks. The scale range for Question 1 is "all the time" (1) to "none of the time" (5); Question 2 range: "more than once a day" (1) to "not at all" (5); Question 3 range: "4 or more nights a week" (1) to "not at all" (5); Question 4 range: "3 or more times per day" (1) to "not at all" (5); Question 5 range: "not controlled at all" (1) to "completely controlled" (5).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01514760
|United States, Arkansas|
|Arkansas Children's Hospital Research Institute|
|Little Rock, Arkansas, United States, 72202|
|Principal Investigator:||Tamara T. Perry, M.D.||University of Arkansas|